Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Evaluate the Clinical Efficacy and Safety of Yogliptin Tablets [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating the efficacy and safety of Yogliptin tablets for type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Yogliptin tablets (Yogliptin)

Snippet

Sponsor: Chengdu Easton Biopharmaceuticals Co,Ltd | Conditions: Type 2 Diabetes | Phase 3 | Status: UNKNOWN